JULIE WILHAUK: Open Payments
NPI 1619949237 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,294 in 24 payments from 9 companies in 2025. Trend: 2023 $417 · 2024 $7,807 · 2025 $1,294
Speaker / faculty: $712Food & beverage: $531Education: $51
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $759 |
| Merck Sharp & Dohme LLC | 10 | $214 |
| PFIZER INC. | 1 | $118 |
| ABBVIE INC. | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| SHIELD THERAPEUTICS INC | 1 | $17 |
Products named: OJJAARA, KEYTRUDA, ELREXFIO, LYNPARZA, JEMPERLI, ELAHERE, ICLUSIG, DATROWAY.
Industry payments across MO — which companies pay providers there.
